TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
CADL

Candel Therapeutics Inc

Healthcare · Biotechnology

11.60$ +2.3% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow CADL
Line item 2019 2020 2021 2022 2023 2024 2025
– – – – – – –
– +111.6% +154.9% +235.3% +23.4% +3.1% -14.6%
– +426.8% +40.6% -22.1% +34.0% +71.9% -28.1%
– +169.0% +114.4% -195.2% – – –
– +245.8% -149.4% – -839.4% – +533.8%
– +828.3% +24.3% -29.3% -64.8% -96.5% +3,568.8%
– – -104.8% -29.3% -78.4% -94.3% +3,400.0%
– – – – – – –
– – +4,228.3% +0.0% -100.0% – –
– -97.8% +14,553.1% -72.2% -100.6% – -40.5%
– – +59.8% -126.7% – – -74.4%
– – – – – – –

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?